(Q46548027)

23 December 2017

title

A randomized clinical trial of valacyclovir in multiple sclerosis (English)

1 reference

23 December 2017

0 references

0 references

J E Friedman

1

1 reference

23 December 2017

J B Zabriskie

2

1 reference

23 December 2017

C Plank

3

1 reference

23 December 2017

D Ablashi

4

1 reference

23 December 2017

J Whitman

5

1 reference

23 December 2017

B Shahan

6

1 reference

23 December 2017

R Edgell

7

1 reference

23 December 2017

M Shieh

8

1 reference

23 December 2017

O Rapalino

9

1 reference

23 December 2017

R Zimmerman

10

1 reference

23 December 2017

D Sheng

11

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

Multiple Sclerosis Journal

published in

1 reference

23 December 2017

volume

11

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

286-295

1 reference

23 December 2017

The multiple causes of multiple sclerosis: the importance of age of infections in childhood.

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Herpesviruses--Immune Escape Artists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Herpesviruses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: identification and characterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1185OA

10.1191/1352458505MS1185OA

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15957509

1 reference

23 December 2017